NEW YORK, Sept. 14 (GenomeWeb News) - Cyntellect has received around $1.5 million in a Phase II Small Business Innovative Research grant to continue developing RNA interference applications on its LEAP platform, the company said today.
...and receive Daily News bulletins.
Already have an account?Login Now.
Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.
Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.
NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.
In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.